MariMed Announces Fourth Quarter and Full Year 2021 Earnings Date
MariMed, Inc. (OTCQX: MRMD) will release its fourth quarter and full year 2021 financial results on March 16, 2022, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
MariMed, Inc. (OTCQX: MRMD) will release its fourth quarter and full year 2021 financial results on March 16, 2022, after market close. A conference call to discuss these results is scheduled for March 17, 2022, at 8:00 a.m. ET. The call will be accessible via MariMed's Investor Relations website, where a playback will be available for 30 days. MariMed is recognized as a leading multi-state cannabis operator, focusing on high-quality products and consistent growth through its management team and proprietary formulations.
Positive
- Upcoming financial results could show growth potential for investors.
- Strong product brands like Betty's Eddies™ and Nature’s Heritage™ are well-established in the market.
Negative
- None.
Details
News Market Reaction – MRMD
The recorded move for MRMD in the trading session of this news was -0.53%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NORWOOD, Mass., Feb. 15, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced it will report its fourth quarter and full year 2021 financial results for the period ending December 31, 2021 on March 16, 2022 after market close. Management will host a conference call on March 17, 2022 at 8:00 a.m. ET to discuss the results.
A webcast will be available and can be accessed via MariMed’s Investor Relations website at www.ir.marimedinc.com. To listen to the live call, please visit the website at least 15 minutes early to register, download and install any necessary audio software. A playback of the call will be archived on MariMed’s website for approximately 30 days.
About MariMed
MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty's Eddies™, Nature’s Heritage™, Bubby’s Baked™, k FUSION™, and Kalm FUSION™. For additional information, visit www.marimedinc.com.
Investor Relations Contact:
Steve West
Vice President, Investor Relations
Email: ir@marimedinc.com
Media Contact:
Trailblaze PR
Email: marimed@trailblaze.co
Company Contact:
Howard Schacter
Chief Communications Officer
Email: hschacter@marimedinc.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.